These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 5770862)
41. [Findings on the therapeutic efficiency and tolerance of ethambutol in pulmonary tuberculosis]. Sala L; Sabot G; D'Ambrogio G Friuli Med; 1967; 22(2):429-43. PubMed ID: 5607705 [No Abstract] [Full Text] [Related]
42. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
43. Drug resistant tuberculosis in Estonia. Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123 [TBL] [Abstract][Full Text] [Related]
44. [Ethambutol in the treatment of chronic pulmonary tuberculosis]. Milovanov D Plucne Bolesti Tuberk; 1970; 22(1):31-7. PubMed ID: 5538338 [No Abstract] [Full Text] [Related]
45. [Observations on the clinical use of ethambutol in certain forms of advanced pulmonary tuberculosis]. Casalone G; Giura R; Lusco G; Tulini F G Ital Mal Torace; 1967; 21(6):295-301. PubMed ID: 5616374 [No Abstract] [Full Text] [Related]
46. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related]
47. [Late results of ethambutol and capreomycin treatment in chronic pulmonary tuberculosis]. Kozakow H; Lachowicz E; Polaczek E; Pszonicka A; Kazimierczak A; Potworowska M; Janowiec M; Niemirowski J; Styszewska H; Rykowska Z; Klimkiewicz H; Grabowska R Gruzlica; 1971 Jul; 39(7):653-61. PubMed ID: 5117144 [No Abstract] [Full Text] [Related]
48. [Ethambutol in the treatment of pulmonary tuberculosis]. Tacquet A; Devulder B Rev Tuberc Pneumol (Paris); 1968; 32(5):729-48. PubMed ID: 5710832 [No Abstract] [Full Text] [Related]
54. [Some findings suggesting a pharmacologic effect of ethambutol on bronchial secretion]. Tsukarmura M Kekkaku; 1969 Feb; 44(2):61-4. PubMed ID: 5772221 [No Abstract] [Full Text] [Related]
55. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations]. Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869 [TBL] [Abstract][Full Text] [Related]
56. [Personal first experiences with ethambutol]. Dosen D; Kotrosan R; Bojanić-Seskar B Plucne Bolesti Tuberk; 1970; 22(3):257-9. PubMed ID: 5206696 [No Abstract] [Full Text] [Related]
57. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing. Laszlo A; Rahman M; Raviglione M; Bustreo F Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369 [TBL] [Abstract][Full Text] [Related]
58. [Note on the clinical trial of ethambutol in sanatorial practice]. Martin-Lelande J; Jaubertie R; Djebbar A Rev Tuberc Pneumol (Paris); 1968; 32(1):116-8. PubMed ID: 5758989 [No Abstract] [Full Text] [Related]
59. Use of molecular techniques to distinguish between treatment failure and exogenous reinfection with Mycobacterium tuberculosis. Krüüner A; Pehme L; Ghebremichael S; Koivula T; Hoffner SE; Mikelsaar M Clin Infect Dis; 2002 Jul; 35(2):146-55. PubMed ID: 12087520 [TBL] [Abstract][Full Text] [Related]
60. Study of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar. Aung WW; Ti T; Than KK; Thida M; Nyein MM; Htun YY; Maung W; Htun A Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):104-10. PubMed ID: 17539254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]